| Table 2.
Information on national evaluations providing data to the Interbull |
| routine evaluation for milk somatic
cells, as provided by participating countries |
|
|
|
|
|
proof |
| Country |
Breed(s) |
h2 |
model |
unit* |
expression** |
|
| Canada |
AYS |
.25 |
AM TD |
SCS(2) |
TA |
|
|
BSW |
.26 |
-"- |
-"- |
-"- |
|
|
GUE |
.33 |
-"- |
-"- |
-"- |
|
|
HOL |
.29 |
-"- |
-"- |
-"- |
|
|
JER |
.26 |
-"- |
-"- |
-"- |
|
| Denmark |
AYS HOL JER |
.11 |
SM MT |
SCC |
TA |
|
| Estonia |
HOL |
.12 |
AM TD |
SCS(2) |
RBV(-) |
|
| Finland |
AYS HOL |
.15 |
AM |
SCS(e) |
RBV(-) |
|
| France |
BSW HOL |
.15 |
AM |
SCS(2) |
RBV(-) |
|
| Germany |
HOL |
.20 |
AM TD |
SCS(2) |
BV |
|
| Netherlands |
BSW HOL JER |
.15 |
AM |
SCS(2) |
RTA(-) |
|
| Sweden |
AYS HOL |
.08 |
SM |
SCC(10) |
RBV(-) |
|
| Switzerland |
HOL |
.31 |
AM TD |
SCS(2) |
BV |
|
| United Kingdom |
AYS GUE HOL JER |
.11 |
AM |
SCC(e) |
TA |
|
| United States |
AYS BSW GUE HOL JER |
.10 |
AM |
SCS(2) |
TA |
|
|
| *log-base used indicated within parenthesis |
| **reversed scale, i.e. high values
are desirable, indicated with in parenthesis |